A subsidiary of UnitedHealth Group Inc. has acquired ChinaGate, a firm that helps drug, device and biotech companies enter the Chinese market, the companies said Wednesday.
I3, a company owned by Minnetonka-based UnitedHealth's technology arm, Ingenix, bought Shanghai-based ChinaGate for an undisclosed sum.
The companies said ChinaGate has extensive experience with the State Food and Drug Administration, China's version of the U.S. Food and Drug Administration, and has helped bring more than 450 medical and consumer health products into the Chinese market.
ChinaGate has also helped clients sell Chinese-made products globally.
CHEN MAY YEE
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
Surging auto insurance rates squeeze drivers, fuel inflation
Relentlessly rising auto insurance rates are squeezing car owners and stoking inflation.
Business
Cisco Systems joins Microsoft, IBM in Vatican pledge to ensure ethical use and development of AI
Tech giant Cisco Systems on Wednesday joined Microsoft and IBM in signing onto a Vatican-sponsored pledge to ensure artificial intelligence is developed and used ethically and to benefit the common good.
Business
German retirees will get an inflation-busting pension increase this year
Germany's Cabinet on Wednesday approved a 4.57% rise in retirees' pensions from this summer, well above the current rate of inflation.
Nation
Editorial Roundup: Minnesota
Minneapolis Star Tribune. April 20, 2024.
Business
The Latest | Germany will resume working with UN relief agency for Palestinians after a review
Germany said Wednesday that it plans to follow several other countries in resuming cooperation with the U.N. relief agency for Palestinians in Gaza after the publication of an independent review of its neutrality.
